Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Regulatory News (REL)

Share Price Information for Relx (REL)

Share Price is delayed by 15 minutes
Get Live Data
2,616.00    33.00 (1.28%)
Bid:
2,608.00
Ask:
2,610.00
Spread: 2.00 (0.077%)
Market Cap: £46.09b
REL Live PriceLast checked at - London Stock Exchange

Intraday Relx Share Chart

3rd Quarter Results

20 Oct 2022 07:00

 

7.00am BST20 October 2022

TRADING UPDATE – October 2022

RELX, the global provider of information-based analytics and decision tools, reports underlying revenue growth for the first nine months of 2022 and updates the full year outlook.

Highlights

Underlying revenue growth year to date +9%

Full year outlook

As we enter the final quarter, momentum remains strong across the group, and we continue to expect full year underlying growth rates in revenue and adjusted operating profit, as well as constant currency growth in adjusted earnings per share, to remain above historical trends.

Risk (35% of H1 2022 revenue)

Underlying revenue growth YTD +7%Business Services growth has remained strong, and the Insurance growth run-rate has improved since the half year. Specialised Industry Data Services has continued to deliver strong growth.Full year outlook: We expect strong underlying revenue growth, in line with historical trends, with underlying adjusted operating profit growth broadly matching underlying revenue growth.

Scientific, Technical & Medical (34% of H1 2022 revenue)

Underlying revenue growth YTD +4%Primary Research has continued to grow well, with the number of articles submitted and published remaining ahead of last year’s elevated levels. Databases & Tools and Electronic Reference has continued to grow strongly.Full year outlook: We expect underlying revenue growth to remain above historical trends, with underlying adjusted operating profit growth slightly exceeding underlying revenue growth.

Legal (21% of H1 2022 revenue)

Underlying revenue growth YTD +5%Further improvement in underlying revenue growth continues to be driven by legal analytics. Renewals remain strong and new sales continue to show positive momentum.Full year outlook: We expect underlying revenue growth to remain well above historical trends, with underlying adjusted operating profit growth continuing to exceed underlying revenue growth.

Exhibitions (10% of H1 2022 revenue)

Underlying revenue growth YTD +85%Revenue growth has been driven by a significant increase in face-to-face activity across most geographies, with digital tools supporting our physical events.Full year outlook: We expect a year of strong underlying revenue growth. The operating result will continue to benefit from the structurally lower cost base.

Underlying growth rates are calculated at constant currencies, excluding the results of acquisitions until twelve months after purchase, and excluding the results of disposals and assets held for sale. Underlying revenue growth rates also exclude exhibition cycling, and timing effects.

-ENDS-

ENQUIRIES:

 

 

Colin Tennant (Investors)

+44 (0)20 7166 5751

 

Paul Abrahams (Media)

+44 (0)20 7166 5724

 

DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This announcement contains forward‐looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results or outcomes of RELX PLC (together with its subsidiaries, “RELX”, “we” or “our”) to differ materially from those expressed in any forward‐looking statement. We consider any statements that are not historical facts to be “forward‐looking statements”. The terms “outlook”, “estimate”, “forecast”, “project”, “plan”, “intend”, “expect”, “should”, “could”, “will”, “believe”, “trends” and similar expressions may indicate a forward‐looking statement. Important factors that could cause actual results or outcomes to differ materially from estimates or forecasts contained in the forward‐looking statements include, among others: the impact of the Covid-19 pandemic as well as other pandemics or epidemics; current and future economic, political and market forces; changes in law and legal interpretations affecting RELX intellectual property rights and internet communications; regulatory and other changes regarding the collection, transfer or use of third‐party content and data; changes in the payment model for RELX products; demand for RELX products and services; competitive factors in the industries in which RELX operates; inability to realise the future anticipated benefits of acquisitions; significant failure or interruption of RELX systems; exhibitors’ and attendees’ ability and desire to attend face‐to‐face events and availability of event venues; changes in economic cycles, severe weather events, natural disasters and terrorism; compromises of RELX cyber security systems or other unauthorised access to our databases; failure of third parties to whom RELX has outsourced business activities; inability to retain high-quality employees and management; legislative, fiscal, tax and regulatory developments; exchange rate fluctuations; and other risks referenced from time to time in the filings of RELX PLC with the US Securities and Exchange Commission. You should not place undue reliance on these forward‐looking statements, which speak only as of the date of this announcement. Except as may be required by law, we undertake no obligation to publicly update or release any revisions to these forward‐looking statements to reflect events or circumstances after the date of this announcement or to reflect the occurrence of unanticipated events.

Notes for Editors About RELX RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 33,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £43bn/€49bn/$48bn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221019005874/en/

Copyright Business Wire 2022

Date   Source Headline
1st Jun 202612:36 pmRNSTotal Voting Rights
1st Jun 202611:22 amRNSTransaction in Own Shares
1st Jun 202611:00 amRNS2025 Final Dividend Euro Equivalent
26th May 20264:27 pmRNSTransaction in Own Shares
26th May 20267:00 amRNSNon-Discretionary Share Buyback Programme
19th May 20263:03 pmRNSAdditional Listing
18th May 202611:43 amRNSTransaction in Own Shares
11th May 202612:54 pmRNSTransaction in Own Shares
5th May 20262:27 pmRNSTransaction in Own Shares
1st May 20262:25 pmRNSTotal Voting Rights
27th Apr 20262:48 pmRNSDirector/PDMR Shareholding
27th Apr 20262:23 pmRNSTransaction in Own Shares
27th Apr 202611:31 amRNSAdditional Listing
23rd Apr 20261:52 pmRNSResult of AGM
20th Apr 20262:06 pmRNSTransaction in Own Shares
13th Apr 202611:18 amRNSTransaction in Own Shares
7th Apr 202612:52 pmRNSTransaction in Own Shares
1st Apr 20263:14 pmRNSTotal Voting Rights
30th Mar 20264:20 pmRNSTransaction in Own Shares
26th Mar 20261:59 pmRNSAdditional Listing
23rd Mar 202610:02 amRNSNon-Discretionary Share Buyback Programme
20th Mar 20265:06 pmRNSTransaction in Own Shares
19th Mar 20265:10 pmRNSTransaction in Own Shares
18th Mar 20264:58 pmRNSTransaction in Own Shares
17th Mar 20265:11 pmRNSTransaction in Own Shares
16th Mar 20265:17 pmRNSTransaction in Own Shares
13th Mar 20265:35 pmRNSTransaction in Own Shares
12th Mar 20265:48 pmRNSTransaction in Own Shares
11th Mar 20264:57 pmRNSTransaction in Own Shares
11th Mar 20264:57 pmRNSTransaction in Own Shares
10th Mar 20265:03 pmRNSTransaction in Own Shares
9th Mar 20265:16 pmRNSTransaction in Own Shares
6th Mar 20265:37 pmRNSTransaction in Own Shares
6th Mar 202611:40 amRNSNotice of AGM
5th Mar 20265:46 pmRNSTransaction in Own Shares
4th Mar 20265:03 pmRNSTransaction in Own Shares
3rd Mar 20265:00 pmRNSTransaction in Own Shares
2nd Mar 20265:00 pmRNSTransaction in Own Shares
2nd Mar 20262:55 pmRNSTotal Voting Rights
27th Feb 20265:24 pmRNSTransaction in Own Shares
26th Feb 20265:36 pmRNSTransaction in Own Shares
25th Feb 20265:04 pmRNSTransaction in Own Shares
25th Feb 202612:28 pmRNSAdditional Listing
24th Feb 20264:58 pmRNSTransaction in Own Shares
23rd Feb 20265:11 pmRNSTransaction in Own Shares
20th Feb 20264:58 pmRNSTransaction in Own Shares
19th Feb 202611:54 amRNSAnnual Financial Report
17th Feb 20265:13 pmRNSTransaction in Own Shares
17th Feb 20267:30 amRNSDirector/PDMR Shareholding
13th Feb 20265:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.